Literature DB >> 24231340

γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.

Roshan V Tiwari1, Parash Parajuli, Paul W Sylvester.   

Abstract

γ-Tocotrienol, a member of the vitamin E family of compounds, displays potent antiproliferative and cytotoxic effects in a variety of cancer cell types at treatment doses that have little or no effect on normal cell viability or growth. Autophagy is a tightly regulated lysosomal self-digested process that can either promote cell survival or programmed cell death, but the role of autophagy in mediating γ-tocotrienol-induced cytotoxicity in breast cancer is not presently completely understood. Mouse (+SA) and human (MCF-7 and MDA-MD-231) mammary tumor cells lines were exposed to 0-40 µmol/L γ-tocotrienol for a 24 h treatment period. γ-Tocotrienol treatment caused a relatively large increase in the accumulation of monodansylcadaverine (MDC)-labeled vacuoles, a marker of autophagosome formation, in all tumor cell lines. Results also showed that γ-tocotrienol treatment induced an increased conversion of microtubule-associated protein, 1A/1B-light chain 3, from its cytosolic form (LC3B-I) to its lipidated form (LC3B-II), increased Beclin-1 levels, and increased acridine orange staining as determined by flow cytometry analysis, providing further evidence of γ-tocotrienol-induced autophagy in these mammary cancer cell lines. In contrast, similar treatment with γ-tocotrienol was not found to increase autophagy marker expression in immortalized mouse (CL-S1) and human (MCF-10 A) normal mammary epithelial cell lines. Treatment with γ-tocotrienol also caused a reduction in PI3K/Akt/mTOR signaling and a corresponding increase in the Bax/Bcl-2 ratio, cleaved caspase-3, and cleaved poly (ADP-ribose) polymerase (PARP) levels in these cancer cell lines, suggesting that γ-tocotrienol-induced autophagy may be involved in the initiation of apoptosis. In summary, these findings demonstrate that the cytotoxic effects of γ-tocotrienol are associated with the induction of autophagy in a mouse and human mammary cancer cells.

Entities:  

Keywords:  Protein kinase B (Akt); autophagy; breast cancer; mammalian target of rapamycin; γ-Tocotrienol

Mesh:

Substances:

Year:  2013        PMID: 24231340     DOI: 10.1177/1535370213511022

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  16 in total

Review 1.  Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols.

Authors:  Chung S Yang; Philip Luo; Zishuo Zeng; Hong Wang; Mokenge Malafa; Nanjoo Suh
Journal:  Mol Carcinog       Date:  2020-02-03       Impact factor: 4.784

2.  γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.

Authors:  R A Ahmed; O A Alawin; P W Sylvester
Journal:  Cell Prolif       Date:  2016-06-21       Impact factor: 6.831

3.  Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.

Authors:  Roshan V Tiwari; Parash Parajuli; Paul W Sylvester
Journal:  Mol Cell Biochem       Date:  2015-06-27       Impact factor: 3.396

4.  Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.

Authors:  P Parajuli; R V Tiwari; P W Sylvester
Journal:  Cell Prolif       Date:  2015-06-19       Impact factor: 6.831

Review 5.  Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols.

Authors:  Constantina Constantinou; Christiana Charalambous; Dimitrios Kanakis
Journal:  Eur J Nutr       Date:  2019-04-16       Impact factor: 5.614

Review 6.  Untangling knots between autophagic targets and candidate drugs, in cancer therapy.

Authors:  Tao Xie; Si-Jia Li; Ming-Rui Guo; Yue Wu; Hang-Yu Wang; Ke Zhang; Xue Zhang; Liang Ouyang; Jie Liu
Journal:  Cell Prolif       Date:  2015-02-04       Impact factor: 6.831

Review 7.  Revisiting the therapeutic potential of tocotrienol.

Authors:  Ranmali Ranasinghe; Michael Mathai; Anthony Zulli
Journal:  Biofactors       Date:  2022-06-20       Impact factor: 6.438

8.  Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?

Authors:  Martin Grimm; Marcel Cetindis; Max Lehmann; Thorsten Biegner; Adelheid Munz; Peter Teriete; Wiebke Kraut; Siegmar Reinert
Journal:  J Transl Med       Date:  2014-07-21       Impact factor: 5.531

Review 9.  Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.

Authors:  Xi Liu; Jimin Xu; Jia Zhou; Qiang Shen
Journal:  Genes Dis       Date:  2020-07-05

Review 10.  Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.

Authors:  Takahiro Eitsuka; Naoto Tatewaki; Hiroshi Nishida; Kiyotaka Nakagawa; Teruo Miyazawa
Journal:  Int J Mol Sci       Date:  2016-09-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.